Duloxetine vs Tofacitinib

Duloxetine vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Duloxetine and Tofacitinib.

Mechanism of Action

Duloxetine: Serotonin-norepinephrine reuptake inhibitor (SNRI).

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Duloxetine — 12 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Duloxetine — C18H19NOS; Tofacitinib — C16H20N6O.

Molecular Weight: Duloxetine — 297.4150 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Duloxetine — Small molecule; Tofacitinib — Small molecule.